+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. POC/Decentralized Infectious Disease Testing Market, 2019-2023: Supplier Shares and Strategies, Country Forecasts, Emerging Technologies, Instrumentation Review

  • PDF Icon

    Report

  • 795 Pages
  • May 2019
  • Region: United States
  • VPG Market Research
  • ID: 4173095
This new 795-page report from the author contains 61 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC infectious disease testing market.

Rationale
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis
  • Review of five POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.


Five-year test volume and reagent sales forecasts for major infectious disease tests by market segment:
  • Physician Offices/Group Practices

  • Emergency Rooms

  • Ambulatory Care Centers

  • Surgery Centers

  • Birth Centers


Sales and Market Share Analysis
  • Market shares of major infectious disease diagnostic reagent and instrument suppliers.


Current and Emerging Products
  • Analysis of infectious disease diagnostic tests performed in POC testing locations.

  • Review of leading infectious disease testing analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.


Technology Review
  • Emerging technologies and their applications for POC testing.

  • Comprehensive listings of companies developing or marketing coagulation testing technologies and products, by assay.


Competitive Assessments
  • Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.


Strategic Recommendations
  • Specific opportunities for new infectious disease testing instruments and reagent systems with potentially significant market appeal during the next five years.

  • Design criteria for POC testing products.

  • Alternative business expansion strategies.

  • Potential market entry barriers and risks.


Methodology
This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and the author's proprietary data files.

Companies Mentioned

  • Abbott

  • Accriva

  • Agilent Technologies

  • Axis-Shield

  • Beckman Coulter/Danaher

  • Becton Dickinson

  • Bio/Data

  • bioMerieux

  • Bio-Rad

  • Cepheid

  • Chrono-Log

  • Corgenix

  • Decode Genetics

  • Diagnostica Stago

  • Diamedix

  • DiaSorin

  • Eiken Chemical

  • EKF Diagnostics

  • Fujirebio

  • Grifols

  • Helena Laboratories

  • Hologic

  • Horiba

  • Instrumentation Laboratory/Werfen

  • Kyowa Medex

  • Leica Biosystems

  • Lonza

  • Nihon Kohden

  • Ortho-Clinical Diagnostics

  • Polymedco

  • Qiagen

  • Roche

  • SDIX

  • Sekisui Diagnostics

  • Sequenom

  • Siemens Healthineers

  • Sienco

  • Sysmex

  • Takara Bio

  • Thermo Fisher

  • Tosoh

  • Wako